EU Stoxx 50 May Fall Despite Approval of Moderna Covid-19 Vaccine

Europe’s benchmark EU Stoxx 50 index may lose ground in the coming days despite the regulatory approval of Moderna’s Covid-19 vaccine as price runs into key resistance.

Related Articles


Your email address will not be published. Required fields are marked *